213 related articles for article (PubMed ID: 33448358)
1. The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders.
Giussani P; Prinetti A; Tringali C
J Neurochem; 2021 Feb; 156(4):403-414. PubMed ID: 33448358
[TBL] [Abstract][Full Text] [Related]
2. Intra- and intercellular trafficking in sphingolipid metabolism in myelination.
Wattenberg BW
Adv Biol Regul; 2019 Jan; 71():97-103. PubMed ID: 30497846
[TBL] [Abstract][Full Text] [Related]
3. Diverse Biological Functions of Sphingolipids in the CNS: Ceramide and Sphingosine Regulate Myelination in Developing Brain but Stimulate Demyelination during Pathogenesis of Multiple Sclerosis.
Dasgupta S; Ray SK
J Neurol Psychol; 2017 Dec; 5(1):. PubMed ID: 30338269
[TBL] [Abstract][Full Text] [Related]
4. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination.
Davis DL; Mahawar U; Pope VS; Allegood J; Sato-Bigbee C; Wattenberg BW
J Lipid Res; 2020 Apr; 61(4):505-522. PubMed ID: 32041816
[TBL] [Abstract][Full Text] [Related]
6. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
7. Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.
Piccinini M; Scandroglio F; Prioni S; Buccinnà B; Loberto N; Aureli M; Chigorno V; Lupino E; DeMarco G; Lomartire A; Rinaudo MT; Sonnino S; Prinetti A
Mol Neurobiol; 2010 Jun; 41(2-3):314-40. PubMed ID: 20127207
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
Skripuletz T; Hackstette D; Bauer K; Gudi V; Pul R; Voss E; Berger K; Kipp M; Baumgärtner W; Stangel M
Brain; 2013 Jan; 136(Pt 1):147-67. PubMed ID: 23266461
[TBL] [Abstract][Full Text] [Related]
9. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
10. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
Silvestroff L; Bartucci S; Pasquini J; Franco P
Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
[TBL] [Abstract][Full Text] [Related]
11. Early myelin lesions in experimental allergic neuritis.
Rosen JL; Brown MJ; Hickey WF; Rostami A
Muscle Nerve; 1990 Jul; 13(7):629-36. PubMed ID: 2388663
[TBL] [Abstract][Full Text] [Related]
12. A unique role for Fyn in CNS myelination.
Sperber BR; Boyle-Walsh EA; Engleka MJ; Gadue P; Peterson AC; Stein PL; Scherer SS; McMorris FA
J Neurosci; 2001 Mar; 21(6):2039-47. PubMed ID: 11245687
[TBL] [Abstract][Full Text] [Related]
13. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
14. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
15. [Protein composition and structure of the myelin sheath. Part I].
Pietrucha-Dutczak M; Marcol W; Korczyńska I; Matuszek I; Górka D; Lewin-Kowalik J
Pol Merkur Lekarski; 2003 Sep; 15(87):268-72. PubMed ID: 14679855
[TBL] [Abstract][Full Text] [Related]
16. Reduced raft-association of NF155 in active MS-lesions is accompanied by the disruption of the paranodal junction.
Maier O; Baron W; Hoekstra D
Glia; 2007 Jun; 55(8):885-95. PubMed ID: 17405145
[TBL] [Abstract][Full Text] [Related]
17. Demyelination in peroxisomal diseases.
Powers JM
J Neurol Sci; 2005 Feb; 228(2):206-7. PubMed ID: 15694208
[No Abstract] [Full Text] [Related]
18. Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.
Verhamme C; King RH; ten Asbroek AL; Muddle JR; Nourallah M; Wolterman R; Baas F; van Schaik IN
J Neuropathol Exp Neurol; 2011 May; 70(5):386-98. PubMed ID: 21487305
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipids in multiple sclerosis.
Jana A; Pahan K
Neuromolecular Med; 2010 Dec; 12(4):351-61. PubMed ID: 20607622
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids: membrane microdomains in brain development, function and neurological diseases.
Olsen ASB; Færgeman NJ
Open Biol; 2017 May; 7(5):. PubMed ID: 28566300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
